Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - TOTAL RECEIVABLES
Total Receivables CTMX - CytomX Therapeutics, Inc.
3.43 M
LAST VALUE
108.43%
2 YEAR CAGR
104.06%
5 YEAR CAGR
30.64%
10 YEAR CAGR